GlassScriptPhysician profile
Rachel W Brown
NPI 1629265012
$14,824.11
in general payments reported to CMS, 2019-2025
16 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,892 · 2020: $2,127 · 2021: $927 · 2022: $1,597 · 2023: $1,780 · 2024: $1,446 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,155 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,154.76 |
| Education | $126.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,647.40 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Amgen INC. | $2,099.45 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Ucb, INC. | $1,342.81 | 2019-2025 | Cimzia, Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,300.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $945.22 | 2021-2025 | |
| Janssen Biotech, INC. | $857.16 | 2020-2025 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $691.03 | 2021-2025 | Saphnelo |
| Horizon Therapeutics Plc | $399.95 | 2019-2023 | Krystexxa |
| Lilly USA, LLC | $180.30 | 2021-2025 | Taltz |
| E.R. Squibb & Sons, L.L.C. | $104.27 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $79.33 | 2019-2020 | |
| Celgene Corporation | $65.21 | 2019 | |
| Pfizer INC. | $61.13 | 2020-2022 | |
| Sandoz INC. | $24.14 | 2024 | Hyrimoz |
| Glaxosmithkline, LLC. | $13.36 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.